603368 Stock Overview
Guangxi LiuYao Group Co., Ltd engages in the wholesale and retail of pharmaceutical products in China.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
Guangxi LiuYao Group Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥22.80 |
| 52 Week High | CN¥25.80 |
| 52 Week Low | CN¥15.12 |
| Beta | 0.34 |
| 1 Month Change | 7.95% |
| 3 Month Change | 29.11% |
| 1 Year Change | -4.32% |
| 3 Year Change | 0.71% |
| 5 Year Change | -8.09% |
| Change since IPO | -43.64% |
Recent News & Updates
Recent updates
Shareholder Returns
| 603368 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | 4.9% | 3.8% | 4.4% |
| 1Y | -4.3% | -33.0% | -12.6% |
Return vs Industry: 603368 exceeded the CN Healthcare industry which returned -34.3% over the past year.
Return vs Market: 603368 exceeded the CN Market which returned -14.2% over the past year.
Price Volatility
| 603368 volatility | |
|---|---|
| 603368 Average Weekly Movement | 5.2% |
| Healthcare Industry Average Movement | 6.9% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 603368's share price has been volatile over the past 3 months.
Volatility Over Time: 603368's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 5,162 | Chaoyang Zhu | web.lzyy.cn |
Guangxi LiuYao Group Co., Ltd engages in the wholesale and retail of pharmaceutical products in China. It also offers smart medicine value-added services. The company was founded in 1981 and is based in Liuzhou, China.
Guangxi LiuYao Group Co., Ltd Fundamentals Summary
| 603368 fundamental statistics | |
|---|---|
| Market cap | CN¥9.04b |
| Earnings (TTM) | CN¥888.87m |
| Revenue (TTM) | CN¥21.25b |
10.2x
P/E Ratio0.4x
P/S RatioIs 603368 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603368 income statement (TTM) | |
|---|---|
| Revenue | CN¥21.25b |
| Cost of Revenue | CN¥18.71b |
| Gross Profit | CN¥2.54b |
| Other Expenses | CN¥1.65b |
| Earnings | CN¥888.87m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.24 |
| Gross Margin | 11.94% |
| Net Profit Margin | 4.18% |
| Debt/Equity Ratio | 68.2% |
How did 603368 perform over the long term?
See historical performance and comparison